AR057362A1 - Procedimientos para preparar un inhibidor de mek - Google Patents

Procedimientos para preparar un inhibidor de mek

Info

Publication number
AR057362A1
AR057362A1 ARP060102448A ARP060102448A AR057362A1 AR 057362 A1 AR057362 A1 AR 057362A1 AR P060102448 A ARP060102448 A AR P060102448A AR P060102448 A ARP060102448 A AR P060102448A AR 057362 A1 AR057362 A1 AR 057362A1
Authority
AR
Argentina
Prior art keywords
procedures
mek inhibitor
prepare
mek
effective
Prior art date
Application number
ARP060102448A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR057362A1 publication Critical patent/AR057362A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente se refiere a procedimientos para preparar el inhibidor de MEK N-[( R)-2,3-dihidroxi-propoxi]-3,4-difluoro-2-(2fluoro-4-yodo-fenilamino)-benzamida que es util para tratar enfermedades mediadas por actividad MEK en mamíferos. La presente proporciona nuevas rutas sintéticas que son seguras, eficaces y rentables cuando se llevan a cabo a escala industrial.
ARP060102448A 2005-06-14 2006-06-12 Procedimientos para preparar un inhibidor de mek AR057362A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69062005P 2005-06-14 2005-06-14

Publications (1)

Publication Number Publication Date
AR057362A1 true AR057362A1 (es) 2007-11-28

Family

ID=36952557

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102448A AR057362A1 (es) 2005-06-14 2006-06-12 Procedimientos para preparar un inhibidor de mek

Country Status (4)

Country Link
JP (1) JP2006348034A (es)
AR (1) AR057362A1 (es)
TW (1) TW200718678A (es)
WO (1) WO2006134469A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130113430A (ko) * 2010-08-05 2013-10-15 케이스 웨스턴 리저브 유니버시티 신경 연결의 발달 장애에 대한 ｅｒｋ 억제제
CN103204822B (zh) 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途
WO2022177557A1 (en) 2021-02-17 2022-08-25 Springworks Therapeutics, Inc. Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof
US11084780B1 (en) 2021-02-17 2021-08-10 Springworks Therapeutics, Inc. Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
US11066358B1 (en) 2021-02-17 2021-07-20 Warner-Lambert Company Llc Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
IL304974A (en) 2021-02-17 2023-10-01 Warner Lambert Co Preparations of mainly pure configuration IV of N-((R)-3,2-dihydroxypropoxy)-4,3-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and their uses
US11571402B2 (en) 2021-02-17 2023-02-07 Springworks Therapeutics, Inc. Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives
AU2001273498B2 (en) * 2000-07-19 2006-08-24 Warner-Lambert Company Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
EP1682495A1 (en) * 2003-10-21 2006-07-26 Warner-Lambert Company LLC Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide

Also Published As

Publication number Publication date
WO2006134469A1 (en) 2006-12-21
TW200718678A (en) 2007-05-16
JP2006348034A (ja) 2006-12-28

Similar Documents

Publication Publication Date Title
AR057362A1 (es) Procedimientos para preparar un inhibidor de mek
BRPI0921063B8 (pt) composto, e, composição agonística para receptor de melanocortina
NO20065907L (no) Nye tetrahydropyridotiofener
CO6930356A2 (es) Compuestos inhibidores de metaloenzimas
ECSP066637A (es) Biaril sulfonamidas y métodos para su uso
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
CR11184A (es) Derivado de oxopirazina y herbicida
CR8092A (es) Pirazolopirimidinas sustituidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos, asi como productos que las contienen
BRPI0519710A2 (pt) aminoÁlcoois tricÍclicos, processo para sua preparaÇço e seu emprego como anti-inflamatàrio
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa
RS54863B1 (sr) Upotreba sredstva za suzbijanje vlažne truleži i postupak suzbijanja iste
EA201071325A1 (ru) Способ и устройство для идентификации человека по характеру его печати с учетом местного распределения клавиш на клавиатуре
AR067258A1 (es) Sierra de mano con ubicacion interna de sujecion accesible
CO6670556A2 (es) Composiciones que constan de ácido shikímico obtenido de materiales a base de palma aceitera y método de producción de las mismas
UY34050A (es) Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol- 2(1h)-il]propoxi}benzamida y un inhibidor de la acetilcolinesterasa y las composiciones farmacéuticas que la contienen
NI201100183A (es) Antagonistas de ccr3 de arilsulfonamida 2, 5 - disustituida
CR10029A (es) Combinacion de productos activos fungicidas
CL2011000100A1 (es) Uso de un inhibidor de desacetilasa de histona para el tratamiento de la enfermedad de hodgkin.
AR057936A1 (es) Combinacion de productos activos fungicidas
CR7989A (es) 7-alquinilamino- triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que la contienen
UY30652A1 (es) N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)piperidin-4-ilideno)metil)benzamida
UY33662A (es) Combinaciones que comprenden inhibidores de dhodh e inhibidores de cox
AR055493A1 (es) Proceso de curtido
CL2009000811A1 (es) Polipeptido con actividad antimicrobiana que comprende una secuencia aminoacidica de al menos un 90% de identidad con la secuencia id no:1 para producir un medicamento para tratar la meningitis; uso de dicho polipeptido para tratar la meningitis.
BRPI0502832A (pt) perfil da acne

Legal Events

Date Code Title Description
FB Suspension of granting procedure